[{"address1": "One Edwards Way", "city": "Irvine", "state": "CA", "zip": "92614", "country": "United States", "phone": "949 250 2500", "website": "https://www.edwards.com", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. It also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.", "fullTimeEmployees": 15800, "companyOfficers": [{"maxAge": 1, "name": "Mr. Bernard J. Zovighian", "age": 56, "title": "CEO & Director", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 2683462, "exercisedValue": 0, "unexercisedValue": 1240500}, {"maxAge": 1, "name": "Mr. Scott B. Ullem", "age": 57, "title": "Corporate VP & CFO", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 1370359, "exercisedValue": 2221842, "unexercisedValue": 2251568}, {"maxAge": 1, "name": "Mr. Donald E. Bobo Jr.", "age": 62, "title": "Corporate Vice President of Strategy & Corporate Development", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 1369117, "exercisedValue": 3641205, "unexercisedValue": 1780611}, {"maxAge": 1, "name": "Mr. Larry L. Wood", "age": 58, "title": "Corporate VP and Group President of TAVR & Surgical Structural Heart", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 1507485, "exercisedValue": 0, "unexercisedValue": 860540}, {"maxAge": 1, "name": "Angela  de la Fuente", "title": "Director of Engineering", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Finn  Haley", "title": "Vice President of Corporate Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel J. Lippis", "age": 48, "title": "Corporate Vice President of JAPAC (Japan, Greater China & Asia Pacific)", "yearBorn": 1976, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Annette Maria Bruls", "age": 53, "title": "Corporate Vice President of EMEA, Canada, & Latin America", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 4, "compensationRisk": 4, "shareHolderRightsRisk": 4, "overallRisk": 4, "governanceEpochDate": 1740787200, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://ir.edwards.com/", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 71.19, "open": 70.92, "dayLow": 70.64, "dayHigh": 71.66, "regularMarketPreviousClose": 71.19, "regularMarketOpen": 70.92, "regularMarketDayLow": 70.64, "regularMarketDayHigh": 71.66, "payoutRatio": 0.0, "beta": 1.123, "trailingPE": 30.303421, "forwardPE": 28.942858, "volume": 4508493, "regularMarketVolume": 4508493, "averageVolume": 4482506, "averageVolume10days": 4656580, "averageDailyVolume10Day": 4656580, "bid": 69.73, "ask": 72.12, "bidSize": 11, "askSize": 13, "marketCap": 41535889408, "fiftyTwoWeekLow": 58.93, "fiftyTwoWeekHigh": 95.73, "priceToSalesTrailing12Months": 7.635976, "fiftyDayAverage": 71.3664, "twoHundredDayAverage": 72.5735, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 38476587008, "profitMargins": 0.76746005, "floatShares": 581844630, "sharesOutstanding": 585755008, "sharesShort": 9451324, "sharesShortPriorMonth": 11897663, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0161, "heldPercentInsiders": 0.00899, "heldPercentInstitutions": 0.88974, "shortRatio": 2.13, "shortPercentOfFloat": 0.0162, "impliedSharesOutstanding": 591987968, "bookValue": 16.987, "priceToBook": 4.174369, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "earningsQuarterlyGrowth": 0.042, "netIncomeToCommon": 1400899968, "trailingEps": 2.34, "forwardEps": 2.45, "lastSplitFactor": "3:1", "lastSplitDate": 1590969600, "enterpriseToRevenue": 7.074, "enterpriseToEbitda": 23.52, "52WeekChange": -0.24763924, "SandP52WeekChange": 0.06429911, "quoteType": "EQUITY", "currentPrice": 70.91, "targetHighPrice": 96.8, "targetLowPrice": 61.0, "targetMeanPrice": 80.14233, "targetMedianPrice": 80.0, "recommendationMean": 2.30303, "recommendationKey": "buy", "numberOfAnalystOpinions": 30, "totalCash": 3975899904, "totalCashPerShare": 6.763, "ebitda": 1635900032, "totalDebt": 700000000, "quickRatio": 3.125, "currentRatio": 4.176, "totalRevenue": 5439499776, "debtToEquity": 6.956, "revenuePerShare": 9.101, "returnOnAssets": 0.082559995, "returnOnEquity": 0.16636999, "grossProfits": 4321999872, "freeCashflow": 1350862464, "operatingCashflow": 542300032, "earningsGrowth": 0.071, "revenueGrowth": 0.094, "grossMargins": 0.79456, "ebitdaMargins": 0.30074, "operatingMargins": 0.25538, "financialCurrency": "USD", "symbol": "EW", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Edwards Lifesciences Corporatio", "corporateActions": [], "postMarketTime": 1743199682, "regularMarketTime": 1743192002, "exchange": "NYQ", "messageBoardId": "finmb_411220", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "regularMarketChangePercent": -0.393312, "regularMarketPrice": 70.91, "postMarketChangePercent": -1.0294787, "postMarketPrice": 70.18, "postMarketChange": -0.73000336, "regularMarketChange": -0.279999, "regularMarketDayRange": "70.64 - 71.66", "fullExchangeName": "NYSE", "averageDailyVolume3Month": 4482506, "fiftyTwoWeekLowChange": 11.980003, "fiftyTwoWeekLowChangePercent": 0.2032921, "fiftyTwoWeekRange": "58.93 - 95.73", "fiftyTwoWeekHighChange": -24.82, "fiftyTwoWeekHighChangePercent": -0.25927085, "fiftyTwoWeekChangePercent": -24.763924, "longName": "Edwards Lifesciences Corporation", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 954167400000, "earningsTimestamp": 1739308500, "earningsTimestampStart": 1745405940, "earningsTimestampEnd": 1745841600, "earningsCallTimestampStart": 1739311200, "earningsCallTimestampEnd": 1739311200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 2.34, "epsForward": 2.45, "epsCurrentYear": 2.44997, "priceEpsCurrentYear": 28.943213, "fiftyDayAverageChange": -0.456398, "fiftyDayAverageChangePercent": -0.0063951383, "twoHundredDayAverageChange": -1.6634979, "twoHundredDayAverageChangePercent": -0.02292156, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.3 - Buy", "cryptoTradeable": false, "displayName": "Edwards Lifesciences", "trailingPegRatio": 4.2635, "__fetch_time": "2025-03-29"}]